Moolec Science (MLEC) Net Cash Flow (2022 - 2024)
Moolec Science (MLEC) reported Net Cash Flow of -$21.0 million for Q4 2024, up 43.87% on a YoY basis from -$14.6 million in Q1 2024, and down 1114.91% sequentially from -$1.7 million in Q3 2024.
Moolec Science (MLEC) Net Cash Flow (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Net Cash Flow data on file, last reported at -$21.0 million in Q4 2024.
- For the quarter ending Q4 2024, Net Cash Flow rose 43.87% year-over-year to -$21.0 million; the trailing twelve-month figure through Mar 2026 stood at -$21.0 million (changed N/A YoY), and the FY2025 full-year result was -$47.4 million, down 544.19% from the prior year.
- Net Cash Flow slipped to -$21.0 million in Q4 2024, from -$1.7 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $9.3 million in Q2 2024 to a low of -$37.4 million in Q4 2023.
- A 3-year average of -$4.3 million and a median of -$515973.5 in 2022 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 4204.67% in 2023, while the deepest fall reached 17683.37% in 2023.
- Tracing MLEC's Net Cash Flow over 3 years: stood at -$592663.0 in 2022, then tumbled by 6212.01% to -$37.4 million in 2023, then jumped by 43.87% to -$21.0 million in 2024.
- Business Quant data shows MLEC's Net Cash Flow at -$21.0 million in Q4 2024, -$1.7 million in Q3 2024, and $9.3 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -21.00 Mn |
| Dec 31, 2024 | -21.00 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Mar 31, 2024 | 2.29 Mn |
| Mar 31, 2024 | 2.29 Mn |
| Dec 31, 2023 | -37.41 Mn |
| Dec 31, 2023 | -37.41 Mn |
| Sep 30, 2023 | -1.70 Mn |
| Sep 30, 2023 | -1.70 Mn |
| Jun 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 4.47 Mn |
| Mar 31, 2023 | -4.35 Mn |
| Mar 31, 2023 | -4.35 Mn |
| Dec 31, 2022 | -592,663.00 |
| Dec 31, 2022 | -592,663.00 |
| Sep 30, 2022 | 9,648.00 |
| Sep 30, 2022 | 9,648.00 |